TrialBlood advances2025

Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study.

Alison Sehgal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.